Remote Ischemic Preconditioning in Cardiac Surgery
Implications of Remote Ischemic Preconditioning on Liver Function in Adults Undergoing Cardiac Surgery: Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
Aim of the work : Evaluation of the role of Remote Ischemic Preconditioning (RIP) on liver function in patients undergoing on-pump cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2020
CompletedFirst Posted
Study publicly available on registry
November 30, 2020
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedApril 20, 2021
April 1, 2021
9 months
September 27, 2020
April 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
liver function test
Direct Bilirubin
3 postoperative days
Study Arms (2)
Remote ischemic preconditioning
ACTIVE COMPARATORSham remote ischemic preconditioning
SHAM COMPARATORInterventions
3 cycles of 5-minutes inflation of a blood pressure cuff to 200mmHg (or at least to a pressure 50mm Hg higher than the systolic arterial pressure) to one upper arm, followed by5-minutes reperfusion with the cuff deflated
3cycles of upper limb pseudo ischemia (low pressure, 5-minutes blood pressure cuff inflation to a pressure of 20 mm Hg and 5-minutes cuff deflation).
Eligibility Criteria
You may qualify if:
- Being candidate for on-pump cardiac surgery.
- Willing to participate in the study
- Ages eligible for the study: 18 to 70 years.
- Gender eligible for the study : both
You may not qualify if:
- Patient refusal.
- Known cause of possible liver function disturbances that includes right heart failure, acute inflammation of gallbladder or any other complication of gallstone disease.
- Active viral and non viral hepatitis.
- Pregnant women.
- History of peripheral nerve disease or peripheral vascular disease of the extremities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University hospital
Asyut, Asyut Governorate, 11111, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor of anesthesia
Study Record Dates
First Submitted
September 27, 2020
First Posted
November 30, 2020
Study Start
April 1, 2021
Primary Completion
January 1, 2022
Study Completion
March 1, 2022
Last Updated
April 20, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share